Prevalence of non-alcoholic fatty liver and characteristics in overweight adolescents in the general population

Overweight and obesity among children and adolescents are increasing. Fatty liver disease (FLD) is an emerging problem in this age group. We investigated prevalence of overweight and non-invasive FLD and associated clinical characteristics in a representative population-based sample of 378 children and adolescents aged 12–20 years who were randomly selected from the general population in Leutkirch, Southern Germany. Overweight was defined as having a body mass index above the 90th percentile for the respective age and sex. About 15% of female (29 out of 194) and 12% of male participants (22/182) were overweight. Among females, only one non-overweight individual showed signs of FLD but in more than one third of the overweight males (8/22) signs of FLD were present. Overweight subjects in general had an unfavourable lipid profile and abnormal concentrations of obesity-related hormones such as significantly lower concentrations of adiponectin and increased levels of inflammatory markers including C-reactive protein and fibrinogen. Overweight males with signs of FLD showed even more severe altered metabolic responses compared to those who were overweight without signs of liver injury. FLD was not explained by alcohol consumption or other chronic liver disease. In this sample of children and adolescents representative of the general population a high prevalence of non-alcoholic fatty liver disease (NAFLD) is found in overweight males. These individuals showed the most severe metabolic alterations compared to non-overweight and overweight individuals without NAFLD indicating even higher risk for future overweight and obesity-related diseases such as type 2 diabetes and cardiovascular disease.

[1]  G. Targher,et al.  Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. , 2005, Diabetes.

[2]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[3]  W. Koenig.  Fibrin(ogen) in cardiovascular disease: an update , 2003, Thrombosis and Haemostasis.

[4]  W. Koenig,et al.  Overweight, physical activity, tobacco and alcohol consumption in a cross-sectional random sample of German adults , 2006, BMC public health.

[5]  D. Cavan,et al.  Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial1 , 2004, BMJ : British Medical Journal.

[6]  M. Akahoshi,et al.  Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan. , 2001, Hypertension research : official journal of the Japanese Society of Hypertension.

[7]  J. Maxwell,et al.  Ultrasound scanning in the detection of hepatic fibrosis and steatosis. , 1986, British medical journal.

[8]  S. Srinivasan,et al.  Obesity and Cardiovascular Risk in Children a , 1993, Annals of the New York Academy of Sciences.

[9]  S. Haffner,et al.  Progression of Plasminogen Activator Inhibitor-1 and Fibrinogen Levels in Relation to Incident Type 2 Diabetes , 2006, Circulation.

[10]  B. Duncan,et al.  The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes. , 2006, Diabetes technology & therapeutics.

[11]  C. Ahn,et al.  Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. , 2004, Archives of internal medicine.

[12]  C. Meisinger,et al.  Lipoprotein-Associated Phospholipase A2 Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General Population: Results From the 14-Year Follow-Up of a Large Cohort From Southern Germany , 2004, Circulation.

[13]  B. Zinman,et al.  Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. , 2004, Diabetes.

[14]  S. Caprio.  Insulin resistance in childhood obesity. , 2002, Journal of pediatric endocrinology & metabolism : JPEM.

[15]  Sonia Caprio,et al.  Obesity and the metabolic syndrome in children and adolescents. , 2004, The New England journal of medicine.

[16]  T. Tagami,et al.  Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. , 2004, Diabetes care.

[17]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[18]  T. Lobstein,et al.  Prevalence of overweight among children in Europe , 2003, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[19]  D. Strachan,et al.  C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. , 2000, Atherosclerosis.

[20]  C. Sigmund,et al.  Ghrelin Inhibits Proinflammatory Responses and Nuclear Factor-κB Activation in Human Endothelial Cells , 2004, Circulation.

[21]  R. Wolfert,et al.  Lp-PLA2: an emerging biomarker of coronary heart disease , 2002, Expert review of molecular diagnostics.

[22]  K. Eguchi,et al.  Association between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults , 2002, American Journal of Gastroenterology.

[23]  Emilio Ros,et al.  Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case–Control Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[24]  Christopher J. Lyon,et al.  Minireview: adiposity, inflammation, and atherogenesis. , 2003, Endocrinology.

[25]  K. Gauvreau,et al.  Prevalence of the Metabolic Syndrome in American Adolescents: Findings From the Third National Health and Nutrition Examination Survey , 2004, Circulation.

[26]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[27]  R. Deutsch,et al.  Influence of Gender, Race, and Ethnicity on Suspected Fatty Liver in Obese Adolescents , 2005, Pediatrics.

[28]  A. Gressner,et al.  Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. , 2004, Clinical chemistry.

[29]  J. Stockman.  Preventing Childhood Obesity by Reducing Consumption of Carbonated Drinks: Cluster Randomised Controlled Trial , 2006 .

[30]  Nader Rifai,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[31]  R. Deutsch,et al.  Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. , 2003, The Journal of pediatrics.

[32]  G. Marchesini,et al.  Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance. , 2003, The Journal of clinical endocrinology and metabolism.

[33]  Jian-Gao Fan,et al.  Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. , 2003, World journal of gastroenterology.

[34]  Yoshimasa Kusano,et al.  Prevalence of fatty liver in Japanese children and relationship to obesity , 1995, Digestive Diseases and Sciences.

[35]  H. Boeing,et al.  Adiponectin and protection against type 2 diabetes mellitus , 2003, The Lancet.

[36]  I. S. Wood,et al.  Adipokines: inflammation and the pleiotropic role of white adipose tissue , 2004, British Journal of Nutrition.

[37]  Jeffrey B. Schwimmer,et al.  Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.

[38]  Wolfgang Haensch,et al.  Organisation , 1892, The Hospital.

[39]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[40]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[41]  J. Schwimmer,et al.  Nonalcoholic fatty liver disease in the pediatric population. , 2004, Clinics in liver disease.

[42]  A. Joseph,et al.  Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. , 1991, Clinical radiology.

[43]  M. Tschöp,et al.  Ghrelin induces adiposity in rodents , 2000, Nature.

[44]  C. Bogardus,et al.  High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. , 2002, Diabetes.

[45]  S. Baik,et al.  Relationship between serum adiponectin concentration, pulse wave velocity and nonalcoholic fatty liver disease. , 2005, European journal of endocrinology.

[46]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[47]  H. Kalies,et al.  Prevalence of overweight and obesity and trends in body mass index in German pre-school children, 1982–1997 , 2002, International Journal of Obesity.

[48]  R Peto,et al.  Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.

[49]  O. Hamdy,et al.  Adipokines, inflammation, and the endothelium in diabetes , 2003, Current diabetes reports.

[50]  C. Meisinger,et al.  C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score: Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany , 2004, Circulation.